We are a research group working at the interface of chemistry and biology to design probes and inhibitors to investigate the intricate workings of human proteins and cells, with particular interest in epigenetics and dementia. We form part of the Structural Genomics Consortium (SGC) and the Alzheimer's Research UK Oxford Drug Discovery Institute (ODDI) at the University of Oxford.



The SGC is a not-for-profit organization which accelerates research by making all its research output available to the scientific community with no strings attached, and by creating an open collaborative network of scientists in hundreds of universities around the world and in nine global pharmaceutical companies.

Synthesis for Biology and Medicine CDT

Want to learn more about the Oxford CDT in Synthesis for Biology & Medicine? Students and the Directors share their views on this DPhil (PhD) programme.